Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Severe alcoholic hepatitis patients \[Maddrey's score \> 32\] aged between 18 to 65 years.~Exclusion Criteria:~* Presence of active infections~* Acute GI bleed~* Hepatorenal syndrome~* Patient unwilling~* DF\>120~* Autoimmune hepatitis~* Hepatitis B, Hepatitis C, HIV cases~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo would be given s/c at days 1, 2, 3, 4, 5 and then every 3rd day till day 28 (total 12 doses)
- G-CSF (Type: EXPERIMENTAL): G-CSF would be given at a dose of 5 microgram/kg daily for 5 days followed by once in 3 days for a total of 12 doses.

Based on this trial design, predict the completion outcome and termination type (if applicable).